Heron Therapeutics Announces Presentation at 22nd Annual Needham Virtual Healthcare Conference

Rhea-AI Summary

Heron Therapeutics (NASDAQ: HRTX) announced that CEO Craig Collard will participate in a fireside chat at the 22nd Annual Needham Virtual Healthcare Conference on April 20, 2023, at 11:45 AM ET. The conference, held from April 17-20, will be virtual, allowing broader access for investors and stakeholders. A live webcast of the event will be available on Heron's website in the Investor Resources section. Heron Therapeutics is focused on developing innovative treatments for unmet patient needs in oncology and acute care, highlighting the company’s commitment to advancing the standard of care. Further details can be accessed through their official website.

Positive

• Participation in a notable healthcare conference could enhance visibility and investor interest.
• Live webcast availability indicates transparency and willingness to engage with stakeholders.

Negative

• None.

SAN DIEGO, April 17, 2023 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced that Craig Collard, Chief Executive Officer of Heron, will participate in a fireside chat on Thursday, April 20, 2023, at 11:45 AM ET at the 22^nd Annual Needham Virtual Healthcare Conference. The conference is being held in a virtual format, April 17-20, 2023.

A live webcast of the fireside chat will be available on the Company's website at www.herontx.com in the Investor Resources section.

About Heron Therapeutics, Inc.

Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on improving the lives of patients by developing and commercializing therapeutic innovations that improve medical care. Our advanced science, patented technologies, and innovative approach to drug discovery and development have allowed us to create and commercialize a portfolio of products that aim to advance the standard-of-care for acute care and oncology patients. For more information, visit www.herontx.com.

Forward-looking Statements

This news release contains "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995. Heron cautions readers that forward-looking statements are based on management's expectations and assumptions as of the date of this news release and are subject to certain risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include, but are not limited to, risks and uncertainties identified in the Company's filings with the Securities and Exchange Commission. Forward-looking statements reflect our analysis only on their stated date, and Heron takes no obligation to update or revise these statements except as may be required by law.

Investor Relations and Media Contact:
David Szekeres
Executive Vice President, Chief Operating Officer
Heron Therapeutics, Inc.
dszekeres@herontx.com
858-251-4447

View original content:https://www.prnewswire.com/news-releases/heron-therapeutics-announces-presentation-at-22nd-annual-needham-virtual-healthcare-conference-301798804.html

SOURCE Heron Therapeutics

FAQ

When will Heron Therapeutics' CEO participate in the Needham Virtual Healthcare Conference?

Craig Collard, CEO of Heron Therapeutics, will participate on April 20, 2023, at 11:45 AM ET.

Where can I watch the Heron Therapeutics fireside chat?

The fireside chat can be accessed via a live webcast on Heron Therapeutics' official website.

What is the focus of Heron Therapeutics?

Heron Therapeutics focuses on developing innovative treatments for unmet needs in oncology and acute care.

Is the Needham Healthcare Conference virtual?

Yes, the 22nd Annual Needham Healthcare Conference is being held in a virtual format from April 17-20, 2023.